1. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
- Author
-
Russo M, Broach J, Sheldon K, Houser KR, Liu DJ, Kesterson J, Phaeton R, Hossler C, Hempel N, Baker M, Newell JM, Zaino R, and Warrick JI
- Subjects
- Aged, Aged, 80 and over, Biomarkers, Tumor analysis, Biopsy, Carcinoma in Situ enzymology, Carcinoma in Situ pathology, Carcinoma in Situ surgery, Carcinoma, Endometrioid enzymology, Carcinoma, Endometrioid pathology, Carcinoma, Endometrioid surgery, Cell Proliferation, DNA Copy Number Variations, DNA Mismatch Repair, DNA Repair Enzymes analysis, Disease Progression, Endometrial Hyperplasia enzymology, Endometrial Hyperplasia pathology, Endometrial Hyperplasia surgery, Endometrial Neoplasms enzymology, Endometrial Neoplasms pathology, Endometrial Neoplasms surgery, Female, Gene Dosage, Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing, Humans, Hysterectomy, Immunohistochemistry, Microsatellite Instability, Middle Aged, Mutation, Phenotype, Biomarkers, Tumor genetics, Carcinoma in Situ genetics, Carcinoma, Endometrioid genetics, Clonal Evolution, Endometrial Hyperplasia genetics, Endometrial Neoplasms genetics
- Abstract
Endometrial intraepithelial neoplasia (EIN) and atypical endometrial hyperplasia (AH) are histomorphologically defined precursors to endometrioid adenocarcinoma, which are unified as EIN/AH by the World Health Organization. EIN/AH harbors a constellation of molecular alterations similar to those found in endometrioid adenocarcinoma. However, the process of clonal evolution from EIN/AH to carcinoma is poorly characterized. To investigate, we performed next-generation sequencing, copy number alteration (CNA) analysis, and immunohistochemistry for mismatch repair protein expression on EIN/AH and endometrioid adenocarcinoma samples from 6 hysterectomy cases with spatially distinct EIN/AH and carcinoma. In evaluating all samples, EIN/AH and carcinoma did not differ in mutational burden, CNA burden, or specific genes mutated (all P>.1). All paired EIN/AH and carcinoma samples shared at least one identical somatic mutation, frequently in PI(3)K pathway members. Large CNAs (>10 genes in length) were identified in 83% of cases; paired EIN/AH and carcinoma samples shared at least one identical CNA in these cases. Mismatch repair protein expression matched in all paired EIN/AH and carcinoma samples. All paired EIN/AH and carcinoma samples had identical The Cancer Genome Atlas subtype, with 3 classified as "copy number low endometrioid" and 3 classified as "microsatellite instability hypermutated." Although paired EIN/AH and carcinoma samples were clonal, private mutations (ie, present in only one sample) were identified in EIN/AH and carcinoma in all cases, frequently in established cancer-driving genes. These findings indicate that EIN/AH gives rise to endometrioid adenocarcinoma by a complex process of subclone evolution, not a linear accumulation of molecular events., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF